The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
Karlsson
Jan Olof G
JO
Brurok
Heidi
H
Towart
Rob
R
Jynge
Per
P
D000970:Antineoplastic Agents / Q000494:pharmacology*; D040761:Biomimetic Materials / Q000494:pharmacology; D003287:Contrast Media / Q000494:pharmacology; D004492:Edetic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000378:metabolism*
D000970:Antineoplastic Agents; D003287:Contrast Media; D011732:Pyridoxal Phosphate; D004492:Edetic Acid; D006861:Hydrogen Peroxide; D013482:Superoxide Dismutase; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid